Autumn Glory Partners’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-577
Closed -$268K 169
2021
Q4
$268K Buy
+577
New +$243K 0.11% 171

Other funds holding ELV

Autumn Glory Partners's ELV Position: Q1 2022 in Review

Autumn Glory Partners sold out of Elevance Health (ELV) in Q1 2022, closing a stake of 577 shares — an estimated $268K sold.

Autumn Glory Partners first reported a position in ELV in Q4 2021 and held it in 1 quarter. The position peaked at $268K in Q4 2021. 1,419 funds tracked by Wall St. Rank hold ELV as of Q1 2022.

  • Autumn Glory Partners reported no remaining Elevance Health position as of Q1 2022 after selling out during the quarter.
  • Autumn Glory Partners sold 577 Elevance Health shares in Q1 2022, an estimated $268K.
  • Autumn Glory Partners first reported a position in Elevance Health in Q4 2021 and held it in 1 quarter.
  • Autumn Glory Partners's Elevance Health position peaked at $268K in Q4 2021.
  • 1,419 funds tracked by Wall St. Rank held Elevance Health as of Q1 2022.

Based on Autumn Glory Partners's 13F filing for Q1 2022, filed 4 May 2022.